MedTrace Logo

Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery

NCT01214382 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-04-06

No results posted yet for this study

Summary

This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.

Conditions

  • Roux en Y Gastric Bypass Surgery

Interventions

DRUG

Sertraline

Single dose sertraline 100 mg, tablet and solution

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • North Dakota State University

    lead OTHER

Principal Investigators

  • Kristine J Steffen, Pharm.D., Ph.D. · Neuropsychiatric Research Institute

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214382 on ClinicalTrials.gov